<DOC>
	<DOCNO>NCT00864578</DOCNO>
	<brief_summary>Elevated intraocular pressure still main risk factor development progression glaucoma . Several drug exist market may decrease IOP glaucomatous patient . However , patient reach target pressure despite multitherapy combination drug , therefore address surgical treatment . Forskolin natural compound receptor-independent adenyl-cyclase activator , increase intracellular cAMP . It show able decrease IOP topical application , mechanism use drug . Aim present study see whether food supplement contain forskolin ( KRONEK ) effect IOP POAG patient reach target pressure , therefore wait list surgical intervention .</brief_summary>
	<brief_title>Effects Forskolin Intraocular Pressure Glaucomatous Patients Under Maximum Tolerated Medical Therapy</brief_title>
	<detailed_description />
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<mesh_term>Colforsin</mesh_term>
	<criteria>Age : 3070 Years Sex : Pathology : POAG Characteristics : Target pressure achieve current treatment Concomitant ocular pathology Previous ocular surgery Known hypersensitivity component KRONEK tablet Concomitant participation trial</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>POAG</keyword>
	<keyword>IOP</keyword>
	<keyword>Forskolin</keyword>
	<keyword>Food supplement</keyword>
</DOC>